DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Cyclacel Pharmaceuticals, Inc. (CYCC)
« Back to company indexCYCC Chatter Timeline
Stock Ticker for CYCC
Most Active Tweeters for CYCC
| User | Tweets |
|---|---|
| @StockWatchHQ | 3 |
| @bulletin_en | 3 |
| @AmericanBanking | 2 |
| @SleekMoneycom | 2 |
| @MichaelSDeVries | 2 |
Recent Tweets for CYCC
 |
@RogelioPiedra Yup. Only a matter of time. $CYCC https://t.co/940kzjkSyZ May 22nd 2019, 1:05pm |
 |
@LTbioinvestor @TraderTexMex $CYCC next ? May 22nd 2019, 11:05am |
 |
@bulletin_en Reviewing Alnylam Pharmaceuticals Inc. $CYCC's results https://t.co/ze3nV8fDvs May 21st 2019, 6:05pm |
 |
@dailypoliticaln Cyclacel Pharmaceuticals $CYCC Rating Increased to Hold at Zacks Investment Research https://t.co/hcG8KLQpw3 May 21st 2019, 4:05am |
 |
@FlyOnTheWallHQ RT @StockWatchHQ: Cyclacel Pharmaceuticals $CYCC CEO Spiro Rombotis Confirming Eli Lilly $LLY Buyout Negotiations In Upcoming Official PR h… May 19th 2019, 3:05pm |
 |
@ScryingBiotech According to FinViz, $VTVT sports an inside ownership of 69%. And, according to BioPharmCatalyst, $CYCC has 4 trial… https://t.co/prMU26r2oe May 19th 2019, 4:05am |
 |
@TheMarketsDaily Cyclacel Pharmaceuticals $CYCC Stock Rating Reaffirmed by HC Wainwright https://t.co/Vg1vepQG59 May 19th 2019, 2:05am |
 |
@dakotafinancial Cyclacel Pharmaceuticals $CYCC Stock Rating Reaffirmed by HC Wainwright https://t.co/CMnF5ACfc8 May 19th 2019, 2:05am |
 |
@StockWatchHQ Cyclacel Pharmaceuticals $CYCC CEO Spiro Rombotis Confirming Eli Lilly $LLY Buyout Negotiations In Upcoming Officia… https://t.co/AaoLW31e1r May 18th 2019, 9:05pm |
|
@dakotafinancial Cyclacel Pharmaceuticals $CYCC Upgraded at Zacks Investment Research https://t.co/l3HrefzMF5 May 18th 2019, 12:05pm |
 |
@TheVCF RT @MichaelSDeVries: I am #Bullish on $CYCC with a target price of $1.40 in 6 months on Vetr => https://t.co/n1J6TkNQIk #Biotechnology #Bio… May 18th 2019, 12:05pm |
 |
@dispatchtribune Cyclacel Pharmaceuticals’ $CYCC Buy Rating Reaffirmed at HC Wainwright https://t.co/dP23S5yX6S May 18th 2019, 12:05pm |
 |
@MichaelSDeVries I am #Bullish on $CYCC with a target price of $1.40 in 6 months on Vetr => https://t.co/n1J6TkNQIk #Biotechnology #BioTech #Stock #CYCC May 18th 2019, 11:05am |
 |
@ThisLincolnian Cyclacel Pharmaceuticals $CYCC Rating Increased to Hold at Zacks Investment Research https://t.co/l9U8nl86Pc May 17th 2019, 8:05pm |
 |
@techwhitepapers $CYCC related @ASCO @pridvimd https://t.co/WB9OMVvbt1 "CDK2 inhibition to help enhance the efficacy of trastuzumab… https://t.co/Lt2cqwje8r May 17th 2019, 9:05am |
 |
@stocknewstimes Zacks: Brokerages Expect Cyclacel Pharmaceuticals Inc $CYCC Will Announce Earnings of -$0.19 Per Share https://t.co/27kStcHQyY May 16th 2019, 11:05pm |
 |
@SleekMoneycom Zacks: Brokerages Expect Cyclacel Pharmaceuticals Inc $CYCC Will Announce Earnings of -$0.19 Per Share https://t.co/fAhjORSWoo #investing May 16th 2019, 11:05pm |
 |
@ConsumerFeed Cyclacel Pharmaceuticals’ $CYCC “Buy” Rating Reiterated at HC Wainwright https://t.co/qIXqmC3JEH May 16th 2019, 7:05am |
 |
@AmericanBanking HC Wainwright Reiterates Buy Rating for Cyclacel Pharmaceuticals $CYCC https://t.co/3LbvsFa30i #stocks May 16th 2019, 7:05am |
 |
@TickerReport Cyclacel Pharmaceuticals Inc $CYCC Given $7.00 Average Price Target by Analysts https://t.co/oruUocyXDU May 16th 2019, 5:05am |
|
@techwhitepapers $CYCC soon ... "INTERROGATING CYCLIN-DEPENDENT-KINASE INHIBITORS AS A NOVEL TREATMENT STRATEGY FOR GLIOBLASTOMA PAT… https://t.co/aVapZSdxKG May 15th 2019, 10:05am |
|
@StockWatchHQ RT @StockWatchHQ: Bragging Rights_Cyclacel Pharmaceuticals $CYCC Confirmation Of Undisclosed Buyout Offer On The Table Following Talks In B… May 15th 2019, 10:05am |
 |
@_B_I_O_T_E_C_H_ LB: $CYCC Multiple Data Reports in 2019; Attractive Risk/Reward Profile; Buy PT $6.00 https://t.co/dllMb6FJ9q May 15th 2019, 6:05am |
 |
@IShopTheWorld RT @MichaelSDeVries: $CYCC Cyclacel Pharmaceuticals Inc (CYCC) Given Consensus Rating of “Strong Buy” by Brokerages => https://t.co/MUjiPm0… May 15th 2019, 5:05am |
|
@MichaelSDeVries $CYCC Cyclacel Pharmaceuticals Inc (CYCC) Given Consensus Rating of “Strong Buy” by Brokerages =>… https://t.co/EvtuiUfEvX May 15th 2019, 5:05am |
|
@StockWatchHQ Bragging Rights_Cyclacel Pharmaceuticals $CYCC Confirmation Of Undisclosed Buyout Offer On The Table Following Talk… https://t.co/CfTrfcZBXc May 14th 2019, 11:05pm |
 |
@khmerxbxboi $AZN you gonna buyout $CYCC May 14th 2019, 9:05pm |
 |
@SiteFocusHQ $CYCC Qualitative Analysis of recent earnings identified Cyclacel Pharmaceuticals, Inc (NASDAQ: CYCC ) business foc… https://t.co/sQJLvFgtOx May 14th 2019, 7:05pm |
 |
@StockNewsWires $CYCC: Cyclacel Pharmaceuticals, Inc. (CYCC) CEO Spiro Rombotis on Q1 …: https://t.co/d1MY19h5nb May 14th 2019, 7:05pm |
 |
@SeekingAlpha $CYCC - Cyclacel Pharmaceuticals, Inc. (CYCC) CEO Spiro Rombotis on Q1 2019 Results - Earnings Call Transcript https://t.co/CSZNCdDidE May 14th 2019, 7:05pm |
 |
@StockNewsNow $CYCC Cyclacel Pharmaceuticals Reports First Quarter 2019 Financial Results https://t.co/LkZJoOn9gi May 14th 2019, 6:05pm |
 |
@proactive_NA $CYCC Cyclacel Pharmaceuticals ends 1Q with nearly $18 million in cash and cash equivalents https://t.co/PsxXZ8Lqjp… https://t.co/qVCs9slGPe May 14th 2019, 4:05pm |
 |
@MarketCurrents $CYCC - Cyclacel Pharmaceuticals beats by $0.08 https://t.co/R7xQHML2SO May 14th 2019, 4:05pm |
 |
@YMuer RT @Stock_News_Now: $CYCC: New SEC Filing for CYCC: Form 8-K (No. 0001144204-19-026002): https://t.co/li1QwzfsFD May 14th 2019, 4:05pm |
 |
@Stock_News_Now $CYCC: New SEC Filing for CYCC: Form 8-K (No. 0001144204-19-026002): https://t.co/li1QwzfsFD May 14th 2019, 4:05pm |
 |
@TranscriptDaily Cyclacel Pharmaceuticals Inc $CYCC Expected to Post Earnings of -$0.19 Per Share https://t.co/3AG2SaCCxV May 14th 2019, 1:05pm |
|
@stocknewstimes Zacks: Cyclacel Pharmaceuticals Inc $CYCC Given Consensus Rating of “Strong Buy” by Brokerages https://t.co/hocVnX21r3 May 13th 2019, 10:05pm |
|
@SleekMoneycom Zacks: Cyclacel Pharmaceuticals Inc $CYCC Given Consensus Rating of “Strong Buy” by Brokerages https://t.co/LEruGveMIa #investing May 13th 2019, 10:05pm |
|
@AmericanBanking Brokerages Expect Cyclacel Pharmaceuticals Inc $CYCC to Post -$0.19 EPS https://t.co/8onX8Gsa7z #stocks May 13th 2019, 10:05pm |
 |
@ZolmaxNews Cyclacel Pharmaceuticals $CYCC to Release Earnings on Tuesday https://t.co/Qq4m3MzQsp May 13th 2019, 3:05am |
 |
@bkfViking123 $cycc at support .... mgt. better tell a story here. https://t.co/tkMPp7YyV2 May 12th 2019, 7:05am |
 |
@registrarjourn Cyclacel Pharmaceuticals $CYCC to Release Earnings on Tuesday https://t.co/aFJHC5FQGD May 12th 2019, 4:05am |
 |
@EnterpriseLeade Cyclacel Pharmaceuticals $CYCC to Release Earnings on Tuesday https://t.co/GVTrCjb3Nh May 12th 2019, 4:05am |
|
@bulletin_en Reviewing Vaccinex Inc. $CYCC's results https://t.co/EA7dHxRSJL May 10th 2019, 11:05pm |
|
@bulletin_en Trillium Therapeutics Inc. $CYCC https://t.co/s2Bhm8cMsH May 10th 2019, 9:05pm |
|
@AmericanBanking Brokerages Anticipate Cyclacel Pharmaceuticals Inc $CYCC to Post -$0.19 Earnings Per Share https://t.co/oxUmUEB0ci #stocks May 9th 2019, 12:05pm |
 |
@macondailynews Zacks: Brokerages Anticipate Cyclacel Pharmaceuticals Inc $CYCC to Announce -$0.19 Earnings Per Share https://t.co/lGQ0Rt2T4H May 9th 2019, 12:05pm |
|
@AmericanBanking Cyclacel Pharmaceuticals $CYCC to Release Earnings on Tuesday https://t.co/TA9nR6C3he #stocks May 9th 2019, 10:05am |
|
@ThisLincolnian Cyclacel Pharmaceuticals $CYCC to Release Earnings on Tuesday https://t.co/aY2XqDt53V May 9th 2019, 10:05am |
 |
@ledgerzette Cyclacel Pharmaceuticals Inc $CYCC Sees Large Decline in Short Interest https://t.co/4AYxdQJ9Me #stocks May 8th 2019, 6:05pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.